North America
India's Zenoti gets Series D extension, hits $1.5b valuation
TPG Capital has led an $80 million Series D extension for Zenoti, an India-founded and US-headquartered software provider for the spa and wellness industry.
DFC backs Openspace, Chiratae funds
The US International Development Finance Corporation (DFC) – formerly the Overseas Private Investment Corporation (OPIC) – has made commitments to funds being raised by Southeast Asia-focused Openspace Ventures and India’s Chiratae Ventures.
Blackstone buys International Data Group from China Oceanwide
The Blackstone Group has agreed to acquire International Data Group (IDG) from China Oceanwide Holdings for an enterprise valuation of $1.3 billion.
TA raises $12.5b for 14th flagship fund
TA Associates, a global growth-oriented investor with a presence in Asia, has closed its 14th flagship fund at the hard cap of $12.5 billion.
Deal focus: NiKang pursues hard-to-drug targets
With big pharma scaling back early-stage discovery, CBC Group is keen to incubate biotech start-ups developing drugs from scratch. NiKang Therapeutics is the first to secure wider investor attention
Vision Fund leads Series C for India-founded Zeta
SoftBank Vision Fund 2 has led a $250 million round for Zeta, an Indian-founded and now US-headquartered banking software-as-a-service (SaaS) provider, at a valuation of $1.4 billion.
Korea's Centroid rallies local support for TaylorMade buyout
Korean GP Centroid Investment Partners is tapping local investors to participate in a KRW1 trillion ($886 million) equity pool in support of its $1.7 billion acquisition of US golf club manufacturer TaylorMade.
Singapore biotech start-up closes $125m Series C
Novo Holdings, which manages the wealth of Denmark’s Novo Nordisk Foundation, has led a $125 million Series C round for Hummingbird Bioscience, a Singapore and US-based drug developer.
China's Panacea, Dell family office raise $200m SPAC
Panacea Venture, a China-focused early-stage healthcare investor, has teamed up with Michael Dell’s family office to raise $200 million for a special purpose acquisition company (SPAC).
Yale's David Swensen dies aged 67
David Swensen, head of the Yale University endowment who pioneered a new approach to institutional investment management, has died aged 67 following a long battle with cancer.
Q&A: B Capital’s Raj Ganguly
In the past few months, B Capital Group has closed a late-stage fund, entered China, and moved forward with a seed-stage vehicle. Co-founder Raj Ganguly explains the firm’s thinking
India's Chargebee closes Series G, hits $1.4b valuation
Sapphire Ventures, Tiger Global Management, and Insight Venture Partners have led a $125 million Series G round for Chargebee, an India-founded and US-headquartered enterprise services business.
China's TuSimple trades flat after $1.3b US IPO
TuSimple, a China and US-based developer of autonomous driving technology for trucks, traded flat on debut following a $1.35 billion IPO at a market capitalization of $8.5 billion.
Deal focus: Partners Group-backed IT play ripens early
Partners Group is set to generate a 5x return on the sale of its 45% stake in GlobalLogic to Hitachi as momentum in corporate digital transformation makes the IT services player a hot commodity
Partners Group, CPPIB exit GlobalLogic to Hitachi
Partners Group and Canada Pension Plain Investment Board (CPPIB) are exiting a combined 90% stake in US-headquartered GlobalLogic to Japan’s Hitachi at an equity valuation of $8.5 billion.
China autonomous driving start-up TuSimple files for US IPO
TuSimple, a China and US-based developer of autonomous driving technology for trucks, has filed for a US IPO. Its backers include CDH Investments, Zhiping Capital, Sina Corporation, and Hong Kong hedge fund Composite Capital.
Invesco leads $155m round for China's Brii Biosciences
Invesco has led a $155 million Series C round for China-focused infectious diseases drug developer Brii Biosciences.
China's Connect Biopharma gains 8% on debut after $191m US IPO
Connect Biopharma, a China-headquartered drug developer specializing in treatments for T cell-driven inflammatory diseases, gained 8.8% on debut following a $191.3 million US IPO.
China biotech makes Asia global healthcare PE leader
A more than 100% year-on-year increase in deal volume saw Asia Pacific overtake North America to become the most active global private equity healthcare market for the first time in 2020.
US-Japan VC hits $75m first close on cross-border fund
SIP Global Partners, a US and Japan-headquartered VC firm, has reached a first close of $75 million on its debut cross-border fund. The target is $150 million.
Rocket Lab to go public via SPAC merger
Rocket Lab, a US-based space technology company that operates primarily in New Zealand, as agreed to merge with a special purpose acquisition company (SPAC) at an enterprise valuation of $4.1 billion.
GPs & SPACs: Filthy lucre?
The global SPAC craze is percolating into Asia, with private equity firms among the sponsors. LPs aren’t necessarily comfortable with the development, but there’s only so much they can do about it
B Capital launches SPAC
B Capital Group, a US-based venture capital firm with a presence in Singapore and a significant Asia portfolio, is looking to raise $300 million for a special purpose acquisition company (SPAC).
China's CITIC sells US dental business
CITIC Capital Partners has exited US-based dental business DDS Lab – the private equity firm’s first acquisition in the US as a lead investor – to RoundTable Healthcare Partners for an undisclosed sum.
